NCT03244228View on ClinicalTrials.gov

A Two Part Study to Assess Safety, PK, PD, and Food Effect of Oral HTL0016878

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 25, 2017

Primary Completion Date

September 23, 2019

Study Completion Date

September 23, 2019

Conditions
Healthy
Interventions
DRUG

HTL0016878

Oral solution

DRUG

Placebo - Concentrate

Matching placebo

Trial Locations (1)

NW10 7EW

Hammersmith Medicines Research, London

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Nxera Pharma UK Limited

INDUSTRY